06.27.24 -- Design And Function Of GMP Transition Spaces

Ensure a stable and reliable supply of essential medications for patients by proactively addressing pharmaceutical supply chain challenges and embracing innovative risk management strategies.

The COVID-19 crisis acted as a catalyst for digital transformation in the industry. Learn how this transformation has impacted trends and new possibilities in the life sciences sector.

There are two basic models of pharma manufacturing: batch and continuous. Here, we compare the two and examine the challenges they bring to containment product design.

Learn how the implementation of a lab management system has enabled one company to accelerate its operations and initiate its journey toward establishing a truly intelligent laboratory.

Advancements in lyophilization technology and research have helped overcome inherent challenges and ensure the safety and efficacy of lyophilized pharmaceuticals.

Data acquisition system tools have come a long way, and now you can learn which trial runs will help you generate the most valuable data.

Medtech OEMs, contract manufacturers, and other partners involved in the device life cycle are increasingly realizing additional benefits by making sustainability a group exercise.

Utilizing off-the-shelf (OTS) devices for drug delivery can offer significant advantages to development programs. Understand the design control responsibilities of a sponsor when using OTS devices.

As interest in HPAPIs as powerful therapeutic mechanisms continues to grow, drug manufacturers must design thoughtful risk-based containment strategies to protect employees and ensure safety.

To meet immediate vaccine demand, aseptic manufacturing capacity must increase quickly. This means environmental monitoring programs must adapt rapidly as well. Thoughtful planning can help.

Review the optimization of the manufacturing process of a pharmaceutical intermediate, and discover how yield can be improved substantially via suitable reaction engineering.

The right CMO can expedite market launch, and an embedded CMO offers many advantages over other CMO models, including access to the extensive capabilities and knowhow of the parent organization.

Discover how companies can de-risk their device selection as they bring this new generation of high-volume, high-viscosity biologics to market.

The transition from academic research and studies to industry research demands that individuals master additional skills, set different objectives, and define “success” differently.

Cell-based assays present a unique challenge due to inherent starting material biological variations. Explore the development of a cell-based potency assay implemented on an automated platform.

How can you optimize your workflow for advanced materials analysis concerning applications in the electronics industry? Discover a step-by-step guide.

Explore how a solvent-free alternative for the production of amorphous solid dispersions (ASDs) not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.